본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists 박현진
(소아청소년과)
박현진, Yun-Mi Song:Ji Won Lee, Yohwan Yeo:김영애. Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists JOURNAL OF KOREAN MEDICAL SCIENCE. 2023-07-05; 2023; 38(29):e230~. IF 4.5 (2022)
Ji Won Lee, Yohwan Yeo
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study 이병일
(표적치료연구과)
이병일, Chi Hoon Park, Kwan-Young Jung:김정훈, Navin Pandit, Miyoun Yoo, Tae Hyun Park:Ji U Choi. Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study SCIENTIFIC REPORTS. 2023-07-04; 2023; 13(1):10805~. IF 4.6 (2022)
김정훈
(암의생명과학과)
박태현
(표적치료연구과)
(grant 수정 필요)NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling 이호
(암의생명과학과)
이호, Mi-Ock Lee:박미경, Na-Lee Ka:전윤, 김선미. (grant 수정 필요)NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling CANCER RESEARCH. 2023-07-03; 2023; 83(18):3045~3058. IF 11.2 (2022)
박미경
(암의생명과학과)
Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients 김학수
(방사선종양학과)
김주영
(방사선의학연구과)
김학수, 김주영:천원중:한미라, 정성훈, 오은상, 이성욱, 이세병, 신동호, 임영경, 정종휘. Feature Importance Analysis of a Deep Learning Model for Predicting Late Bladder Toxicity Occurrence in Uterine Cervical Cancer Patients CANCERS. 2023-07-02; 2023; 15(13):3463~. IF 5.2 (2022)
천원중
(양성자치료센터)
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) 엄현석
(부속병원)
엄현석, Sung-Hoon Jung:Mihee Kim:정종헌. Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) ANNALS OF HEMATOLOGY. 2023-07-01; 2023; 102(8):2233~2240. IF 3.5 (2022)
Mihee Kim
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association_(CMH) 이인준
(중재의학연구과)
이인준, Hyunchul Rhim:조유리, Jin Woo Choi:Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association_(CMH) CLINICAL AND MOLECULAR HEPATOLOGY. 2023-07-01; 2023; 29(3):521~541. IF 8.9 (2022)
조유리
(간담도췌장암센터)
(grant 수정 필요)Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study 우상명
(종양면역연구과)
우상명, Jang-Hwan Choi:전중원, Thanaporn Viriyasaranon:고영환, 이우진, Jae Hee Cho, Min Kyu Jung, Seong-Hun Kim, Hyo Jung Kim. (grant 수정 필요)Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study CANCERS. 2023-06-28; 2023; 15(13):3392~. IF 5.2 (2022)
전중원
(중재의학연구과)
Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R) 임명철
(자궁난소암센터)
임명철, Sung Jong Lee:Ji Geun Yoo:김지현, 박은영, Imhyeon Kim. Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R) JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-06-27; 2023; 34:e72~. IF 3.9 (2022)
Ji Geun Yoo
(grant 수정 필요)LKB1/STK11 tumor suppressor reduces angiogenesis by directly interacting with VEGFR2 in tumorigenesis 노승배
(암전이연구과)
노승배, Chang Hoon Lee:노승배:Hyun Jung Byun, Boh-Ram Kim. (grant 수정 필요)LKB1/STK11 tumor suppressor reduces angiogenesis by directly interacting with VEGFR2 in tumorigenesis BIOMOLECULES & THERAPEUTICS. 2023-06-26; 2023; 31(4):456~465. IF 3.7 (2022)
노승배
(암전이연구과)
Correspondence: 4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell 최범규
(종양면역연구과)
최범규, Ki Taek Nam:조은정, ROHITSINGH:한충용, 김선희, 박보미, 신동훈, 한성은. Correspondence: 4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell CELLULAR & MOLECULAR IMMUNOLOGY. 2023-06-26; 2023; 20(9):1077~1080. IF 24.1 (2022)
조은정
(종양면역연구과)
ROHITSINGH
(종양면역연구과)